UK markets close in 3 hours 32 minutes

RUA Life Sciences plc (RUA.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
11.74-0.01 (-0.09%)
As of 12:41PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 7.29M
Enterprise value 7.24M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.39
Price/book (mrq)1.95
Enterprise value/revenue 3.88
Enterprise value/EBITDA -3.34

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3-71.69%
S&P500 52-week change 325.59%
52-week high 358.75
52-week low 38.50
50-day moving average 310.42
200-day moving average 313.48

Share statistics

Avg vol (3-month) 3666.43k
Avg vol (10-day) 3518.92k
Shares outstanding 562.06M
Implied shares outstanding 662.06M
Float 820.36M
% held by insiders 118.78%
% held by institutions 120.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 301 Sept 2003

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -100.05%
Operating margin (ttm)-171.29%

Management effectiveness

Return on assets (ttm)-27.86%
Return on equity (ttm)-40.56%

Income statement

Revenue (ttm)1.87M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)-28.10%
Gross profit (ttm)N/A
EBITDA -2.16M
Net income avi to common (ttm)-1.87M
Diluted EPS (ttm)-0.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)493k
Total cash per share (mrq)0.02
Total debt (mrq)445k
Total debt/equity (mrq)11.92%
Current ratio (mrq)2.67
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-1.57M
Levered free cash flow (ttm)-1.71M